Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 12, 2017 – Amneal Biosciences announced the FDA approval of an AP-rated generic version of Bristol-Myers Squibb’s Kenalog- 40 (triamcinolone acetonide) injection.
Download PDF
Return to publications
